Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
169.7 USD | +2.94% | +0.53% | -6.00% |
May. 14 | BeiGene Highlights New Hematology Portfolio and Pipeline Data at EHA2024 | CI |
May. 09 | Beigene Q1 Loss Shrinks as Revenue Grows; Company's Shares Nearly 7% Up | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.00% | 17.24B | |
+7.41% | 113B | |
+11.16% | 106B | |
+0.41% | 22.27B | |
-11.68% | 22.22B | |
-5.99% | 19.43B | |
-37.85% | 17.87B | |
+7.05% | 14.29B | |
+35.19% | 12.52B | |
+300.86% | 8.6B |
- Stock Market
- Equities
- BGNE Stock
- News BeiGene, Ltd.
- JPMorgan Chase Adjusts Price Target on BeiGene to $300 From $297, Maintains Overweight Rating